NCT00076687 - Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function | Biotech Hunter

Enrollment

155

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions

StrokeMuscle SpasticityMotor Neuron Disease

Interventions

BIOLOGICAL

botulinum toxin Type A

botulinum toxin Type A 240 U injection on Day 1, Week 12, Week 18

BIOLOGICAL

botulinum toxin Type A

botulinum toxin Type A 360 U injection at Day 1, Week 12, Week 18

DRUG

saline

Saline injection at Day 1, Week 12, Week 18

Trial Locations (4)

Miami

Prague

Szeged

Warsaw